Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
Press releases published on April 8, 2025
Drug Delivery Devices Market to Hit $446.75B by 2034, Growing at 4.90% CAGR from $290.41B in 2025
EIN Presswire
·
April 8, 2025
As per MRFR analysis, the Drug Delivery Devices Market Size was estimated at 276.84 (USD Billion) in 2024. US, NY, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- The Drug Delivery Devices market is a crucial segment within the broader healthcare and …
Cardiovascular Devices Market to Hit $107.89 Billion by 2034, Driven by 6.60% CAGR
EIN Presswire
·
April 8, 2025
Cardiovascular devices market to grow from USD 60.68B in 2025 to USD 107.89B by 2034 at a CAGR of 6.60%, says MRFR analysis US, NY, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- The global demand for cardiovascular devices is experiencing …
Digital Biomarkers Market Forecasted to Reach USD 35.75 Billion By 2034, at an Impressive 22.60% CAGR
EIN Presswire
·
April 8, 2025
Digital Biomarkers: Charting New Paths in Healthcare – A Market Overview US, NY, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- The digital biomarkers market is experiencing exponential growth, fueled by the convergence of technological advancements …
Guidewires Market to Hit $1.57B by 2034, Growing at 3.80% CAGR from $1.12B in 2025
EIN Presswire
·
April 8, 2025
As per MRFR analysis, the Guidewires Market Growth Size was estimated at 1.08 (USD Billion) in 2024. US, NY, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- The global guidewires market is experiencing steady growth, driven by the increasing …
Healthcare BPO Market Expected to Hit USD 0.28 Billion by 2032 with a Remarkable 10.01% CAGR
EIN Presswire
·
April 8, 2025
Outsourcing will be increasingly utilized to enhance patient engagement and improve the overall patient journey. US, NY, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- The global Healthcare BPO market is experiencing substantial growth, driven by …
First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients
GlobeNewswire
·
April 8, 2025
LA JOLLA, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced enrollment of the …
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
GlobeNewswire
·
April 8, 2025
WARREN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a healthcare company with dedicated efforts in immunotherapy and artificial intelligence, today announced that Mittul Mehta, Chief …
Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease
GlobeNewswire
·
April 8, 2025
HUNTSVILLE, Ala., April 08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today announced the closing of a $ …
National Minority Quality Forum Announces 2025 National Minority Health Month Theme: “Health Unlocked: Access, Alignment, Action”
GlobeNewswire
·
April 8, 2025
Washington, D.C., April 08, 2025 (GLOBE NEWSWIRE) -- The National Minority Quality Forum (NMQF) proudly announces the 2025 theme for National Minority Health Month: “Health Unlocked: Access, Alignment, Action.” This year’s theme recognizes the evolving …
Myriad Genetics Announces Inducement Awards
GlobeNewswire
·
April 8, 2025
SALT LAKE CITY, April 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today that in connection with the hiring of Mr. Donnelly as chief commercial officer, …
AMN Healthcare to Hold First Quarter 2025 Earnings Conference Call on Thursday, May 8, 2025
GlobeNewswire
·
April 8, 2025
DALLAS, April 08, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its first quarter 2025 financial results and second quarter 2025 outlook on Thursday, May 8, 2025, at 5:00 p.m. Eastern Time. …
Gender Reassignment Surgery Market Set to Reach USD 9.0 Billion, with a Healthy 14.78% CAGR Till Forecasts 2035
EIN Presswire
·
April 8, 2025
Urethral lengthening and scrotoplasty These procedures are technically complex but increasingly sought after due to improved success rates and outcomes. US, NY, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- Gender Reassignment Surgery Market: A …
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025
GlobeNewswire
·
April 8, 2025
PORTLAND, Maine, April 08, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer
GlobeNewswire
·
April 8, 2025
SAN DIEGO, April 08, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases …
Clover Health to Report First Quarter 2025 Financial Results on May 6, 2025
GlobeNewswire
·
April 8, 2025
WILMINGTON, Del., April 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2025 financial results after market close on Tuesday, May 6 …
NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy
GlobeNewswire
·
April 8, 2025
CALABASAS, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, today announced that …
Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities
GlobeNewswire
·
April 8, 2025
SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global Digital Holdings Inc., conducting business as QumulusAI …
Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting
GlobeNewswire
·
April 8, 2025
Oral Presentation Features Phase 3 Data Showing Rapid Recovery and Durable Benefit of Tanruprubart (formerly ANX005) on Clinically Meaningful Measures across Multiple Stages of GBS Disease Education Campaign for Healthcare Providers called Move GBS Forward …
Nurix Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
April 8, 2025
NX-5948 assigned the nonproprietary name “bexobrutideg” U.S. FDA Orphan Drug Designation granted to bexobrutideg for the treatment of Waldenström macroglobulinemia Achieved $7M in milestones and a $15M license extension fee from ongoing collaboration with …
Brachytherapy Device Market Expected to Achieve a Strong 10.35% CAGR, to Reach USD 8.7 Billion by 2035
EIN Presswire
·
April 8, 2025
Limited expertise in certain regions restricts the widespread adoption of brachytherapy US, NY, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- Brachytherapy Device Market: Targeted Radiation Therapy for Effective Cancer Treatment Market Overview: …